Advanced Search
ZHOU Yan, WU Zhencun, CHENG Jianjun, JIA Tianjun. Association of HLA-E Gene Polymorphisms with Genetic Susceptibility to Breast Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 190-193. DOI: 10.3971/j.issn.1000-8578.2015.02.020
Citation: ZHOU Yan, WU Zhencun, CHENG Jianjun, JIA Tianjun. Association of HLA-E Gene Polymorphisms with Genetic Susceptibility to Breast Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 190-193. DOI: 10.3971/j.issn.1000-8578.2015.02.020

Association of HLA-E Gene Polymorphisms with Genetic Susceptibility to Breast Carcinoma

More Information
  • Received Date: February 19, 2014
  • Revised Date: September 16, 2014
  • Objective To investigate the association between HLA-E gene polymorphisms and genetic susceptibility of female breast carcinoma in Han Nationality in Zhangjiakou, China. Methods HLA-E typing was performed for 200 breast cancer patients and 114 healthy controls from Zhangjiakou area by polymerase chain reaction-sequence-specific priming (PCR-SSP). Results Two alleles of HLA-E could be detected, HLA-E*0101 and HLA-E*0103; simultaneously three genotypes were detected, namely HLA-E*0101/0101, HLA-E*0101/0103 and HLA-E*0103/0103. The frequencies of HLA-E*0103 allele and HLA-E*0103/HLA-E*0103 genotype were significant different between healthy controls and breast cancer patients(P<0.01). The risk of breast cancer was significantly increased in HLA-E*0103/ HLA-E*0103 genotype(OR=2.05, P=0.004). Conclusion HLA-E gene polymorphisms are associated with the development of female breast cancer of the Han in Zhangjiakou, China; moreover, HLA-E*0103/ HLA-E*0103 genotype is probably the susceptible genotype.
  • [1]
    Alanazi MS, Parine NR, Shaik JP, et al. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients[J].Plos One, 2013, 8(3): e59555.
    [2]
    Ferguson R, Ramanakumar AV, Richardson H, et al. Human leukocyte antigen(HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence[J].Hum Immunol, 2011, 72(4): 337-41.
    [3]
    Benevolo M, Mottolese M, Tremante E, et al. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis[J]. J Transl Med, 2011, 9: 184.
    [4]
    Leos Kren, Ondrej Slaby, Katarina Muckova, et al. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance? [J]. Neuropathology, 2011, 31(2): 129-34.
    [5]
    Wang JY, Xu Q, Wu SJ, et al. Expression and significance of HLA-G and HLA-E in the tissue of ovarian malignant tumor[J]. Shangdong Yi Yao, 2010, 50(15): 1-3.[王建英, 许茜, 吴淑娟, 等. 卵巢恶性肿瘤组织中HLA-G、HLA-E的表达及意义[J]. 山东 医药, 2010, 50(15): 1-3.]
    [6]
    Qiao GF, Wang XD, Pan YL. Study on the association of lung cancer with HLA-E allele[J].Liaoning Yi Xue Yuan Xue Bao, 20 07, 28(3): 50-2.[乔高峰, 王晓东, 潘玉玲. HLA-E基因多态性 与肺癌的相关性研究[J]. 辽宁医学院学报, 2007, 28(3): 50-2.]
    [7]
    Hirankarn N, Kimkong I, Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma[J]. Tissue Antigens, 20 04, 64(5): 588-92.
    [8]
    Liu XX, Pan FH, Tian W. Characterization of HLA-E polymorphism in four distinct populations in Mainland China[J]. Tissue Antigens, 2012, 80(1): 26-35.
    [9]
    Paladini F, Belfiore F, Cocco E, et al. HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia[J]. Arthritis Res Ther, 2009, 11(6): R171.
    [10]
    Park KS, Park JS, Nam JH, et al. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet’s disease[J]. Tissue Antigens, 2007, 69(2): 13 9-44.
    [11]
    Zhu ZL, Wu XJ, Wu DP, et al. Influence of HLA-E polymorphism on cytomegalovirus infection after HLA-matched hematopoietic stem cell transplantation[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2013, 21(4): 990-4.[朱子玲, 吴小津, 吴德沛, 等. HLA-E基因 的多态性对同胞全相合造血干细胞移植后巨细胞病毒感染的 影响[J] 中国实验血液学杂志, 2013, 21(4): 990-4.]
    [12]
    Zeng X, Chen H, Gupta R, et al. Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility[J]. Exp Dermatol, 2013, 22(10): 67 9-81.
    [13]
    Zhou X, Wu CY. Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer[J].Sichuan Da Xue Xue Bao(Yi Xue Ban), 2012, 43 (6): 807-11.[周鑫, 吴诚义. CD44基因多态性与乳腺癌遗传易 感性及临床病理参数的关系[J]. 四川大学学报(医学版), 2012, 43 (6): 807-11.]
    [14]
    Zhou X, Wu CY. Association of p73 polymorphisms with genetic susceptibilities to breast cancer: a case-control study[J].Zhongguo Zhong Liu Lin Chuang, 2012, 39(21): 1615-8.[周鑫, 吴诚义. p73 基因多态性与乳腺癌遗传易感性的关系[J]. 中国肿瘤临床, 20 12, 39(21): 1615-8.]
    [15]
    de Kruijf EM, Sajet A, van Nes JG, et al. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients[J]. J Immunol, 2010, 185(12): 7452-9.
  • Related Articles

    [1]Wang Li, Wei Feng, Nie Weiwei, Tang Lin, Chen Longbang, Guan Xiaoxiang. Systematic Review of Relationship between Genetic Polymorphism of p73 4G14C-4A14T and Susceptibility to Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 526-531. DOI: 10.3971/j.issn.1000-8578.2012.05.008
    [2]Wang Lu, Song Zhaoxia, Liu Bing, Sun Haibo, Zhu Wei. Association between Brg1 Single Nucleotide Polymorphism and Laryngo Carcinoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(02): 130-132. DOI: 10.3971/j.issn.1000-8578.2012.02.003
    [3]WU Jian-qiu, ZHANG Xiao-mei, LIU De-lin, LI Su-ping, MA Guo-jian, LI Jin-tian, ZHANG Yuan-ying. Polymorphisms in Splicing Regulation Region of Metastasis Suppressor Gene KAI1/CD82 and Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(01): 63-66. DOI: 10.3971/j.issn.1000-8578.2011.01.018
    [4]LI Li-hua, ZHOU Xi-ke, HE Jie, SONG Ming-xu, LIU Zhi-hui, WU Er-bin. Prognostic Impact of CYP2B6 Q172H and K262R Polymorphism on Breast Cancer Patients Treated with Cyclophosphamide-based Adjuvant Chemotherapy[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1387-1390. DOI: 10.3971/j.issn.1000-8578.2010.12.014
    [5]LIU Zhi-hui, Guo Zi-jian, HUANG Zhao-hui, SONG Ming-xu, ZHOU Xi-ke, LI Li-hua. Relationships between Single Nucleotide Polymorphisms of TNRC9 rs12443621 and Risk of Breast Cancer in Chinese Women[J]. Cancer Research on Prevention and Treatment, 2010, 37(10): 1156-1158. DOI: 10.3971/j.issn.1000-8578.2010.10.015
    [6]YAO Qun-feng, CHEN Xin, XUE Jin-ruo, LUO Min, XIAO Ling, YANG Chao. Relationship of Polymorphisms of MTHFR Gene and Hypermethylation of Tumor Suppressor Gene in Lung Cancers[J]. Cancer Research on Prevention and Treatment, 2010, 37(05): 531-534. DOI: 10.3971/j.issn.1000-8578.2010.05.012
    [7]LIU Jing, SUN Ye-huan, CHEN Ying, CHEN Peng, HEI Jin-xuan, GENG Jiao, SUN Liang. Methylenetetrahydrofolate Reductase Polymorphisms and Susceptibility to Esophageal Cancer in Chinese Population: Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 213-217. DOI: 10.3971/j.issn.1000-8578.2010.02.024
    [8]WU Guang-heng, ZHANG Jia-ying, LU Pei-xin. Association of Single Nucleotide Polymorphism of Interferon-gamma Gene +874 Site and Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2008, 35(09): 651-652. DOI: 10.3971/j.issn.1000-8578.3191
    [9]LI Xin-min, PAN Xiao-lin, YANG An-qiang, ZHENG Xing-zheng, ZHOU Qiu-yuan. Correlation between HPV16 E6 and p53Arg72Pro Polymorphisms[J]. Cancer Research on Prevention and Treatment, 2008, 35(09): 613-616. DOI: 10.3971/j.issn.1000-8578.2457
    [10]SU Yan-hua, WANG Xiao-li, XU Shun-qing. The Polymorphisms of CYP1A1 and GSTM1 Genes on Individual Susceptibility to Lung Cancer:Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2006, 33(05): 324-327. DOI: 10.3971/j.issn.1000-8578.2902
  • Cited by

    Periodical cited type(1)

    1. 刘艳春,贾儒渊,樊志慧,王朝凤,苏海燕,曹文娟,徐丹丹. 表皮生长因子受体在食管鳞状细胞癌组织中的表达及其临床意义. 临床误诊误治. 2024(10): 35-38+43 .

    Other cited types(0)

Catalog

    Article views (1645) PDF downloads (483) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return